Table 2 Time on treatment from LOT1 initiation, abatacept compared to other bDMARD therapy
bDMARD therapy | Median (months) | R-Mean (months) | Max Follow Up (months) | Month 12 (%) | Month 24 (%) | Month 36 (%) | P-value |
|---|---|---|---|---|---|---|---|
Abatacept | 53.4 | 41.2 | 53.4 | 85.6% | 70.9% | 70.9% | W:< 0.01* LR:< 0.01* |
Other | 17.4 | 31.4 | 139.9 | 63.4% | 39.3% | 31.7% |